Brind.

GoSun reserved units for its EV charger; CancerVax aims to disrupt cancer treatment; and Benzinga reported on GLPI's quarterly revenue and earnings.

1 report, 0 independent Updated Jun 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

GoSun reserved units for its EV charger; CancerVax aims to disrupt cancer treatment; and Benzinga reported on GLPI's quarterly revenue and earnings.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Benzinga promoted CancerVax and GoSun as investment opportunities, noting Benzinga's potential revenue through links.Sub-event
  2. Updates on GoSun's EV charger business, CancerVax's market goals, and Benzinga's report on GLPI.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet